Literature DB >> 25349113

The miR-146a polymorphism and susceptibility to systemic lupus erythematosus and rheumatoid arthritis : a meta-analysis.

Y H Lee1, S-C Bae.   

Abstract

OBJECTIVE: The aim of this study was to explore whether the miR-146a polymorphism (rs2910164) confers susceptibility to systemic lupus erythematous (SLE) and rheumatoid arthritis (RA).
METHODS: A meta-analysis was conducted on the association of the miR-146a polymorphism with SLE and RA.
RESULTS: Five studies with 2013 patients and 2555 controls were included in the meta-analysis. Meta-analysis revealed no association between SLE and the miR-146a G allele (odds ratio, OR = 1.007, 95 % confidence interval, CI = 0.910-1.114, p = 0.888). Additionally, no associations were found between the miR-146a polymorphism and SLE using recessive or dominant models, or homozygote contrast. Meta-analysis using allele contrast, recessive and dominant models, as well as homozygote contrast failed to reveal an association between the miR-146a polymorphism and RA (OR for G allele = 1.114, 95 % CI = 0.892-1.391, p = 0.342).
CONCLUSION: This meta-analysis demonstrates that the miR-146a polymorphism is not associated with susceptibility to SLE and RA. However, considering the small number of studies, further studies are needed to confirm this result.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25349113     DOI: 10.1007/s00393-014-1509-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  18 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 2.  Association of MicroRNA-146a with autoimmune diseases.

Authors:  Wang-Dong Xu; Man-Man Lu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

3.  Genome scan meta-analysis of rheumatoid arthritis.

Authors:  S J Choi; Y H Rho; J D Ji; G G Song; Y H Lee
Journal:  Rheumatology (Oxford)       Date:  2005-11-08       Impact factor: 7.580

4.  A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility.

Authors:  Anthoula Chatzikyriakidou; Paraskevi V Voulgari; Ioannis Georgiou; Alexandros A Drosos
Journal:  Joint Bone Spine       Date:  2010-09-25       Impact factor: 4.929

Review 5.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

6.  A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.

Authors:  Teng Xu; Ying Zhu; Qing-Kun Wei; Yunfei Yuan; Fan Zhou; Yi-Yuan Ge; Jian-Rong Yang; Hang Su; Shi-Mei Zhuang
Journal:  Carcinogenesis       Date:  2008-08-18       Impact factor: 4.944

7.  Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene.

Authors:  S E Löfgren; J Frostegård; L Truedsson; B A Pons-Estel; S D'Alfonso; T Witte; B R Lauwerys; E Endreffy; L Kovács; C Vasconcelos; B Martins da Silva; S V Kozyrev; M E Alarcón-Riquelme
Journal:  Genes Immun       Date:  2012-01-05       Impact factor: 2.676

8.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

9.  MiR-146a polymorphism is associated with asthma but not with systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican patients.

Authors:  S Jiménez-Morales; R Gamboa-Becerra; V Baca; B E Del Río-Navarro; D Y López-Ley; R Velázquez-Cruz; Y Saldaña-Alvarez; G Salas-Martínez; L Orozco
Journal:  Tissue Antigens       Date:  2012-07-24

Review 10.  MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.

Authors:  Prasun J Mishra; Joseph R Bertino
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

View more
  8 in total

Review 1.  MicroRNA control of B cell tolerance, autoimmunity and cancer.

Authors:  Changchun Xiao; David Nemazee; Alicia Gonzalez-Martin
Journal:  Semin Cancer Biol       Date:  2020-08       Impact factor: 15.707

2.  The occurrence of cervical cancer in Uygur women in Xinjiang Uygur Autonomous Region is correlated to microRNA-146a and ethnic factor.

Authors:  Li Ma; Yi Hong; Chang Lu; Yanxia Chen; Cailing Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  mir-146a genetic polymorphisms in systemic lupus erythematosus patients: Correlation with disease manifestations.

Authors:  Basima A El-Akhras; Yasser B M Ali; Samir A El-Masry; Iman H Bassyouni; Ibrahim H El-Sayed; Roba M Talaat
Journal:  Noncoding RNA Res       Date:  2022-05-26

Review 4.  Nociceptive related microRNAs and their role in rheumatoid arthritis.

Authors:  S Reyes-Long; J L Cortes-Altamirano; D Clavijio-Cornejo; M Gutiérrez; C Bertolazzi; C Bandala; C Pineda; A Alfaro-Rodríguez
Journal:  Mol Biol Rep       Date:  2020-08-01       Impact factor: 2.316

Review 5.  The real culprit in systemic lupus erythematosus: abnormal epigenetic regulation.

Authors:  Haijing Wu; Ming Zhao; Christopher Chang; Qianjin Lu
Journal:  Int J Mol Sci       Date:  2015-05-15       Impact factor: 5.923

6.  An Updated Meta-Analysis of the Associations Between MicroRNA Polymorphisms and Susceptibility to Rheumatoid Arthritis.

Authors:  Mi Zhou; Bo Jiang; Mao Xiong; Xin Zhu
Journal:  Front Physiol       Date:  2018-11-15       Impact factor: 4.566

7.  Association of microRNAs genes polymorphisms with arthritis: a systematic review and meta-analysis.

Authors:  Yingqi Xiao; Hui Liu; Li Chen; Yang Wang; Xiang Yao; Xiaolian Jiang
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

8.  Functional polymorphisms in pre-miR146a and pre-miR499 are associated with systemic lupus erythematosus but not with rheumatoid arthritis or Graves' disease in Mexican patients.

Authors:  Isidro Alemán-Ávila; Mayra Jiménez-Morales; Olga Beltrán-Ramírez; Rosa Elda Barbosa-Cobos; Silvia Jiménez-Morales; Fausto Sánchez-Muñoz; Guillermo Valencia-Pacheco; Luis M Amezcua-Guerra; Yaneli Juárez-Vicuña; Dulce Milagro Razo-Blanco Hernández; María Concepción Aguilera-Cartas; Ricardo F López-Villanueva; Oscar Peralta-Zaragoza; Carlos Tovilla-Zárate; Julian Ramírez-Bello
Journal:  Oncotarget       Date:  2017-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.